How2Exit

MAY 30, 2023

We are seeing an increasing amount of private equity entering the veterinary space, both at the clinic level and the pet product level. Private equity is already investing heavily in the pet industry, and it is expected to continue to grow. making it highly competitive to get into.

Private Equity 130

Private Equity Business Equities Investment 130

Focus Investment Banking

DECEMBER 26, 2023

The 6th annual Midwest M&A/Private Equity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.

Private Equity 52

Private Equity M&A Equities Insurance 52

Focus Investment Banking

JULY 31, 2023

This article focuses on how medical practices are valued by private equity-backed groups, and to an extent, health systems and other strategic acquirers. Emergency medicine, radiology, and anesthesiology groups may also be candidates for acquisition by longer-established acquirers. We explore each in turn below.

Medical 52

Medical Private Equity Healthcare Professional Services 52

Sun Acquisitions

FEBRUARY 6, 2023

CHICAGO, IL ­- February 6, 2023 – Sun Acquisitions is pleased to announce the successful sale of Trouvaille Med Spa to MedSpa Partners Inc. Through the acquisition of Trouvaille Med Spa, MedSpa Partners Inc. Through the acquisition of Trouvaille Med Spa, MedSpa Partners Inc. About MedSpa Partners Inc.

Sale 52

Sale Acquisitions Mergers and Acquisitions Medical 52

Focus Investment Banking

SEPTEMBER 17, 2024

The platform includes the acquisitions of GEM Manufacturing, Coining MFG, National Manufacturing Co. Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets.

Investment Banking 52

Investment Banking Acquisitions Investment Bank 52

Focus Investment Banking

MAY 31, 2024

Serving a variety of end markets, including aerospace & defense, electronics and industrials, National offers especially deep experience in the medical end market across various implantable devices, including pacemakers, neuromodulation devices, defibrillators, batteries and capacitors. appeared first on FOCUS.

Investment Banking 52

Investment Banking Manufacturing Bank Banking 52

How2Exit

AUGUST 2, 2023

With over 15 years of experience in the technology industry, Kurt has a deep understanding of how technology applies to mergers and acquisitions. rn Summary: rn Kurt Stein discusses the role of technology, specifically artificial intelligence (AI), in mergers and acquisitions. Let's dive in.

Mergers and Acquisitions 130

Mergers and Acquisitions Mergers Acquisitions M&A 130

Focus Investment Banking

JULY 20, 2023

CORE, a private equity firm focused on manufacturing, industrial technology, and industrial services, previously acquired GEM, a provider of precision deep-drawn metal components and mechanical assemblies, in February 2023. PMP”), a provider of specialty stamping and machining services. FOCUS represented CORE in this transaction.

Investment Banking 52

Investment Banking Manufacturing Bank Banking 52

The Deal

AUGUST 9, 2023

3 spot on The Deal’s private equity league table for law firms. The combination with Waller gave Holland & Knight increased capabilities in healthcare, well as in private equity, financial services, real estate and litigation. As of March, the merged entity had nearly 2,000 attorneys in 34 offices in the U.S.

Business 52

Business Private Equity Middle Market Medical 52

Focus Investment Banking

APRIL 1, 2024

Summary Private equity-backed Physician Practice Management (“PPM”) companies in the ENT & Allergy space continued a conservative growth trajectory during Q1 2024. Most platforms are seeking acquisitions in their home regions and are especially interested in larger, more diversified practices.

Private Equity 52

Private Equity Equities Negotiation Investment 52

The New York Times: Mergers, Acquisitions and Dive

JUNE 23, 2024

People have grown more attached to their pets — and more willing to spend money on them — turning animal medicine into a high-tech industry worth billions.

Business 144

Business Private Equity Mergers and Acquisitions Medical 144

Tyton Partners

APRIL 10, 2024

Excolere Equity Partners is a leading middle market private equity firm that leverages its deep sector experience and strategic and operational expertise to accelerate the growth and enhance the impact of companies in the Education and Human Capital sector. ISP Schools is a portfolio company of OMERS Private Equity.

Education 52

Education Medical Private Equity Equities 52

How2Exit

JUNE 19, 2023

John Prothrow had a background in mergers and acquisitions and had worked on the buy side of transactions. The brand also receives many medical referrals from podiatrists and other foot specialists. He also acquired a competitor called Happy Feet Plus in Florida, which has been a good acquisition for the brand.

Mergers and Acquisitions 130

Mergers and Acquisitions Business IT Acquisitions 130

Focus Investment Banking

JUNE 13, 2023

On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 While the biggest recent deal, OneOncology is hardly the first oncology platform to be sold to a private equity group. US Oncology Network.

Hospitality 52

Hospitality Private Equity Mergers and Acquisitions Medical 52

Sica Fletcher

JULY 1, 2020

Update on Private Equity and Insurance Brokerages In our ,, previous article , we reported that the COVID-19 pandemic had not diminished the pace of mergers and acquisitions transactions we are seeing in the insurance agency and brokerage sector. Private equity firms continue to drive transaction pace and value.

Private Equity 52

Private Equity Insurance Debt Equities 52

Focus Investment Banking

SEPTEMBER 27, 2024

Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Dulles Eye Associates has joined ReFocus Eye Health as a supported practice.

Investment Banking 52

Investment Banking Bank Banking Investment 52

Focus Investment Banking

SEPTEMBER 27, 2024

They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. FOCUS managing directors Eric Yetter and Andy Snyder advised Mid-Michigan ENT in this partnership.

Investment Banking 52

Investment Banking Bank Banking Investment 52

Peak Frameworks

SEPTEMBER 19, 2023

For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Solganick & Co.

JANUARY 9, 2024

January 9, 2024 2023: A Year of Strategic Consolidation and Diversification In 2023, the Healthcare IT sector witnessed a significant transformation marked by strategic mergers and acquisitions (M&A). Billion): Private equity firm Thoma Bravo acquired NextGen Healthcare for an enterprise value of $1.8

Healthcare 52

Healthcare M&A IT Mergers and Acquisitions 52

Focus Investment Banking

MARCH 28, 2024

Summary Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once private equity groups and lenders become comfortable with the interest rate environment. The typical ophthalmology PPM is also regionally focused. A third group (e.g.,

Private Equity 52

Private Equity Equities Valuation Acquisitions 52

Focus Investment Banking

NOVEMBER 30, 2023

They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. “We Parallel ENT & Allergy is backed by Trinity Hunt Partners , a growth-oriented private equity firm with deep healthcare experience. “We who serves as Michigan ENT’s managing partner.

Investment Banking 52

Investment Banking Bank Banking Investment 52

Focus Investment Banking

AUGUST 15, 2023

Washington, DC, (August 15, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that it has added two new managing directors, Mike McCraw and William R. Bill”) Snow.

Investment Banking 52

Investment Banking Bank Banking Management 52

Periculum Capital

MAY 14, 2024

Periculum Capital Company, LLC is pleased to announce it has advised Micro-Dyn Medical Systems, Inc., a leading health care software company, in its acquisition by The Brydon Group. based private equity investor that specializes in acquiring software businesses in partnership with top mid-career executives.

Sale 52

Sale IT Mergers and Acquisitions Advisory 52

Tyton Partners

FEBRUARY 3, 2025

As the Federal Reserve moves toward a more predictable and potentially lower rate trajectory, financing conditions are expected to improve, enabling both strategic buyers and private equity investors to pursue transactions with greater confidence.

Education 52

Education Sale Investors Medical 52

The Deal

JUNE 15, 2023

focuses on the healthcare services, medical device and healthcare IT sectors. .- and Cincinnati-based RC Capital tapped McDermott Will & Emery LLP for legal advice. RC Capital, which has offices in Cincinnati and Raleigh, N.C., In 2022 it was raising its seventh fund with a $300 million target.

Capital 52

Capital Healthcare Equities Medical 52

Cooley M&A

JANUARY 23, 2024

For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7

M&A 52

M&A Mergers and Acquisitions Acquisitions Pharmaceutical 52

Growth Business

NOVEMBER 23, 2023

The fund will not invest in hardware, medical devices or consumer social networks. Entrée Capital Entrée Capital invests predominantly in software, with a current focus in enterprise, SaaS, marketplaces, big data and fintech. Entrée Capital provides multi-stage funding for innovative seed, early and growth companies all over the world.

Investment 111

Investment Funds Capital Business 111

Software Equity Group

APRIL 30, 2024

In turn, it has led to a surge of mergers and acquisitions in the Government software space, particularly for SaaS businesses. As an M&A advisor, Software Equity Group keeps a close eye on this space , and we’ve been deeply engaged in our own right, advising on more than 20 Government transactions for our clients in recent years.

Government 52

Government M&A Mergers and Acquisitions Business 52

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

The year started off with a bang, with mega-deals such as Microsoft’s pending $69 billion acquisition of Activision Blizzard, Elon Musk’s $44 billion acquisition of Twitter and Broadcom’s pending $61 billion acquisition of VMware inked in quick succession. Tech M&A in 2022 was a tale of two halves. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Sidley Shareholder Litigation

MARCH 25, 2025

Vice Chancellor Lasters opinion captioned In re Dura Medic Holdings, Inc. The case involved claims brought by a co-founder of Dura Medic, Inc. Dura Medic or Company) against affiliates of Comvest, a private equity backer that acquired Dura Medic in 2018 through subsidiary affiliates.

Private Equity 52

Private Equity Finance Finance Equities 52

Focus Investment Banking

FEBRUARY 17, 2025

Behavioral Health, Infusion, and Staffing firms top the list in BRGs survey Many lower middle market private equity groups have revisited their investment priorities as we enter 2025, making room for new opportunities across healthcare verticals. ophthalmology and ENT). However, we expect fewer new platform formations in PPM.

Private Equity 52

Private Equity Healthcare Equities Investors 52

How2Exit

MARCH 17, 2025

E272: How to Buy a Business with Almost No Money: SBA Loan Strategies & Franchise Goldmines - Watch Here About the Guest: Beau Eckstein is a business coach and expert in SBA lending, business acquisitions, and franchising. Eckstein isn’t just a lender—he’s lived the highs and lows of business ownership.

Business 130

Business Finance Finance Private Equity 130

Focus Investment Banking

FEBRUARY 11, 2025

McKessons acquisition of PRISM Vision Group is an important milestone for private equitys investments in optometry practices. PRISM was founded in 2018 with Quad-C Managements acquisition of NJ Retina, a large Retina practice in New Jersey.

Private Equity 52

Private Equity Healthcare Equities Medical 52

Focus Investment Banking

MARCH 7, 2025

Private equity investments in healthcare provider practices are getting more mature and changing the way buyers and sellers approach transactions. Deal activity has been high across dentistry, veterinary, and the physician specialties, with more than 100 private equity backed platforms established and completing their own add-on deals.

Healthcare 52

Healthcare Private Equity Equities Professional Services 52

Mergers and Inquisitions

MARCH 5, 2025

Biotech Hedge Funds Definition: Biotech hedge funds bet for or against public biopharmaceutical companies, typically based on catalysts such as clinical trial results, acquisitions, and liquidations; many funds focus on early-stage companies, but some also invest in platform companies, and some also make private-market investments.

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64

Lake Country Advisors

JANUARY 13, 2025

An M&A advisor is a specialized professional who guides businesses through the intricate mergers and acquisitions process. Financial Buyers : Private equity firms and investment groups interested in businesses with strong cash flow and growth potential. What Is an M&A Advisor?

Broker 52

Broker M&A Business Negotiation 52